512 related articles for article (PubMed ID: 22588654)
1. [A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].
Meyer I; Frank D; Janssens U
Dtsch Med Wochenschr; 2012 May; 137(21):1096-9. PubMed ID: 22588654
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine-induced reset osmostat syndrome: case of a 79-year-old depressed woman.
Ranieri P; Franzoni S; Rozzini R; Trabucchi M
J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):75-8. PubMed ID: 9188023
[TBL] [Abstract][Full Text] [Related]
3. [Syndrome of inappropriate antidiuretic hormone secretion in the course of treatment with venlafaxine--case report].
Chojnacka M; Swiecicki Ł
Psychiatr Pol; 2011; 45(6):933-9. PubMed ID: 22335135
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Burke D; Fanker S
Aust N Z J Psychiatry; 1996 Apr; 30(2):295-8. PubMed ID: 8811276
[TBL] [Abstract][Full Text] [Related]
5. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis.
Humayun MA; Cranston IC
BMC Endocr Disord; 2017 Nov; 17(1):69. PubMed ID: 29110656
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine hyponatraemia: incidence, mechanism and management.
Roxanas M; Hibbert E; Field M
Aust N Z J Psychiatry; 2007 May; 41(5):411-8. PubMed ID: 17464733
[TBL] [Abstract][Full Text] [Related]
7. Hyponatremia with venlafaxine.
Masood GR; Karki SD; Patterson WR
Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
[TBL] [Abstract][Full Text] [Related]
8. Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine.
Romero S; Pintor L; Serra M; Plana T; Navarro V; Gastó C; Goldstein B
Gen Hosp Psychiatry; 2007; 29(1):81-4. PubMed ID: 17189754
[TBL] [Abstract][Full Text] [Related]
9. Syndrome of inappropriate secretion of antidiuretic hormone due to desvenlafaxine.
Lee Gt; Leung Jl
Gen Hosp Psychiatry; 2013; 35(5):574.e1-3. PubMed ID: 22818163
[TBL] [Abstract][Full Text] [Related]
10. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
11. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
Mali P; Muduganti SR; Mujibur R; Murali N
WMJ; 2015 Apr; 114(2):66-8. PubMed ID: 26756059
[TBL] [Abstract][Full Text] [Related]
12. [SIADH with epileptic seizures and coma in fluoxetine therapy].
Romerio SC; Radanowicz V; Schlienger RG
Praxis (Bern 1994); 2000 Mar; 89(10):404-10. PubMed ID: 10731855
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
Chen S; Zhao JJ; Tong NW; Guo XH; Qiu MC; Yang GY; Liu ZM; Ma JH; Zhang ZW; Gu F
J Clin Pharmacol; 2014 Dec; 54(12):1362-7. PubMed ID: 24906029
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
Han SW; Yi JH; Kang KP; Kim HY; Kim SW; Choi HY; Ha SK; Kim GH; Kim YW; Jeong KH; Shin SK; Kim HJ
J Korean Med Sci; 2018 Apr; 33(15):e112. PubMed ID: 29629516
[TBL] [Abstract][Full Text] [Related]
15. Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Yamamoto H; Kimura K; Horikirizono H; Tamura Y; Kambayashi S; Baba K; Okuda M; Mizuno T; Igase M
J Vet Med Sci; 2023 Oct; 85(10):1047-1051. PubMed ID: 37587049
[TBL] [Abstract][Full Text] [Related]
16. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
Estilo A; McCormick L; Rahman M
Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
[TBL] [Abstract][Full Text] [Related]
17. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
Harbeck B; Lindner U; Haas CS
Endocrine; 2016 Sep; 53(3):872-3. PubMed ID: 26961548
[No Abstract] [Full Text] [Related]
18. Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
Yamashita T; Yoshida M; Yamada H; Asano T; Aoki A; Ikoma A; Kusaka I; Kakei M; Ishikawa SE
Intern Med; 2014; 53(8):845-9. PubMed ID: 24739604
[TBL] [Abstract][Full Text] [Related]
19. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
Rollino C; Balbiano R; Caramello P; Roccatello D
G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662
[TBL] [Abstract][Full Text] [Related]
20. Hypokalemia with venlafaxine.
Shang CY; Soong WT; Lin HN
J Clin Psychiatry; 2002 Nov; 63(11):1049-50. PubMed ID: 12469691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
